Clinical Trial: A Study to Compare Blood Levels of Two Different Dosage Formulations of the Study Medicine Called CGRP Receptor Antagonist in Healthy Adults

U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07261371) titled 'A Study to Compare Blood Levels of Two Different Dosage Formulations of the Study Medicine Called CGRP Receptor Antagonist in Healthy Adults' on Nov. 21.

Brief Summary: The purpose of this study is to assess the bioequivalence (medicines that may have different names or be made in different ways, but have the same effect on the body) of different formulations of a CGRP receptor antagonist in healthy adult participants.

The study is seeking participants who are:

1. Healthy males and females 18 years of age or older

2. Willing and able to comply with all scheduled visits, treatment plan, lifestyle considerations, and other study pro...